Syngene International Ltd

Syngene International Earnings Call Transcript: Key Takeaways

Syngene reports a transitional quarter with sequential recovery but YoY declines due to the absence of the large Librela revenue stream.

Syngene International Investor Presentation: Key Takeaways

Q2 FY27 revenue Rs 833 Cr (down 9% YoY, up 13% QoQ). Operating EBITDA margin 18% on forex hedge losses. PAT before exceptionals Rs 38 Cr (down 44% YoY). Focus on integrated CRDMO and first Bayview biologics deal.

Syngene International Results Update

Syngene reported Q2 FY27 revenue of Rs 833 Crore, up 13% sequentially, with PAT of Rs 32 Crore. Release includes P&L highlights and business updates.

Syngene International Management Change

Syngene reports changes in senior management: two heads move from SMP to Non-SMP, Ajay Tandon resigns effective October 30, 2026, and CFO Deepak Jain plans to leave. The CFO is a KMP, so this is a material leadership change.

Syngene International Q2 FY27 Results: Net Profit ₹32.2 Cr, Down 52.0% YoY

Syngene International Ltd reported revenue from operations of ₹832.7 Cr (-8.6% YoY) and net profit of ₹32.2 Cr (-52.0% YoY) for Q2 FY27.

Key figure

Net profit ₹32.2 Cr · -52.0% YoY

Syngene International Other Announcement

Syngene International Limited has submitted the quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.

Syngene International Board Meeting Date

Syngene International Limited will hold a board meeting on October 27, 2026, to approve the standalone and consolidated financial results for the quarter ended September 30, 2026.

Syngene International Management Change

Syngene International Limited announced the resignation of Mr. Pramuch Goel, Head of Corporate Affairs & Communications and Senior Management Personnel, effective September 21, 2026.

Syngene International Other Announcement

Syngene International Limited has issued a communication to shareholders regarding the remittance of the final dividend for the financial year 2025-26.

Syngene International Employee Stock Options

Syngene International has granted 14,26,061 Performance Share Units (PSUs) to eligible employees under the company's 2023 Long Term Incentive Performance Share Plan.

Syngene International Acquisition Worth ₹2.52 Cr

Syngene International Limited is investing ₹2.52 Crore to acquire a 12.44% equity stake in Ampin C&I Power Twelve Private Limited for renewable energy power consumption.

Value

₹2.52 Cr